Reviva Pharmaceuticals Holdings, Inc. (RVPH:OTC) closed at $0.475 on October 15, 2026, down 0.67% on the day. The stock trades 96.9% below its 52-week high of $15.40 and 81.3% above its 52-week low of $0.262. Reviva Pharmaceuticals Holdings, Inc. is part of the Finance sector.
Reviva Pharmaceuticals Holdings Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of internally discovered therapies that address unmet medical needs in the areas of central nervous system, respiratory, and metabolic diseases. The company is currently focused on the development of its lead product candidate, RP5063, which targets schizophrenia, bipolar disorder, major depressive disorder, behavioral & psychotic symptoms, dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, and also respiratory indications such as pulmonary arterial hypertension & idiopathic pulmonary fibrosis.
Find more stocks like RVPH with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.